53 results
Page 2 of 3
8-K
EX-99.2
58140x4r0
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
POS AM
wpf5obby
3 Mar 22
Prospectus update (post-effective amendment)
8:29am
8-K
EX-99.1
0wmaabs91 ti
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am
POSASR
cw0b5r9
3 Mar 22
Automatic shelf registration (post-effective amendment)
7:00am
8-K
EX-99.2
57w2yops6wu9msmgu3rx
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
EX-99.1
qaqz pu8dnla
5 Aug 21
Passage Bio Reports Second Quarter 2021 Financial Results and Provides Recent Business Highlights
7:01am
DEF 14A
kzs6x64yknumc 9epq
14 Apr 21
Definitive proxy
4:01pm
S-3ASR
f0ohraps5y6
5 Mar 21
Automatic shelf registration
5:22pm
10-K
13i9xu9 exohxlays0
3 Mar 21
Annual report
8:01am
424B1
tgaav4bwc 0ztk
22 Jan 21
Prospectus with pricing info
4:31pm
DRS
krm4fdr6eu9orn
18 Dec 20
Draft registration statement
12:00am